Anemia Drugs Market - Global Outlook and Forecast 2021-2027

Anemia Drugs Market - Global Outlook and Forecast 2021-2027

  • Market Monitor Global
  • November 2021
  • Pharmaceutical
  • 94 pages

Report Description

This report contains market size and forecasts of Anemia Drugs in global, including the following market information:
Global Anemia Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Anemia Drugs Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Anemia Drugs companies in 2020 (%)
The global Anemia Drugs market was valued at 12170 million in 2020 and is projected to reach US$ 14400 million by 2027, at a CAGR of 4.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anemia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anemia Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Anemia Drugs Market Segment Percentages, By Type, 2020 (%)
Oral
Injection

Global Anemia Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Anemia Drugs Market Segment Percentages, By Application, 2020 (%)
Iron Deficiency Anemia
Chronic Kidney Disease related Anemia
Sickle Cell Anemia
Aplastic Anemia

Global Anemia Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Anemia Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Anemia Drugs revenues share in global market, 2020 (%)
Key companies Anemia Drugs sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Anemia Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Global Blood Therapeutics (GBT)
Bluebird Bio
GlycoMimetics
Mast Therapeutics
Fibrogen
Akebia Therapeutics
Bayer AG
Eli Lilly
Regen Biopharma
Acceleron Pharma
Celgene Corporation
Onconova Therapeutics
Pieris Pharmaceuticals

Have query on this report?

Make an Enquiry
1 Introduction to Research & Analysis Reports
1.1 Anemia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
List of Tables
Table 1. Key Players of Anemia Drugs in Global Market
Table 2. Top Anemia Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anemia Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anemia Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Anemia Drugs Sales by Companies, (K Pcs), 2016-2021

Success Stories

Our Clients